Cover Image

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

Designing optimal (neo)adjuvant therapy is a crucial aspect of the treatment of non-small-cell lung carcinoma (NSCLC). Standard methods of chemotherapy, radiotherapy, and immunotherapy represent effective strategies for treatment. However, in some cases with high metastatic activity and high levels...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zdeněk Kejík (Author), Robert Kaplánek (Author), Petr Dytrych (Author), Michal Masařík (Author), Kateřina Veselá (Author), Nikita Abramenko (Author), David Hoskovec (Author), Martina Vašáková (Author), Jarmila Králová (Author), Pavel Martásek (Author), Milan Jakubek (Author)
Format:	Book
Published:	MDPI AG, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity
by: Veronika Talianová, et al.
Published: (2022)

The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course
by: A. Taddei, et al.
Published: (2015)

Selection of Metastatic Breast Cancer Cell-Specific Aptamers for the Capture of CTCs with a Metastatic Phenotype by Cell-SELEX
by: Wan-Ming Li, et al.
Published: (2018)

Navigating the redox landscape: reactive oxygen species in regulation of cell cycle
by: Viktoria Mackova, et al.
Published: (2024)

Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
by: Diego de Miguel-Perez, et al.
Published: (2023)

Circulating tumour DNA: a minimally invasive biomarker for tumour detection and stratification
by: Arif Surani
Published: (2016)

Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells' resistance to anti-tumour drugs
by: Meng Chi, et al.
Published: (2023)

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy
by: Laura Keller, et al.
Published: (2018)

Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma
by: Atsuko Ashida, et al.
Published: (2019)

Doplňující pedagogické studium z perspektivy odborných pedagogických kompetencí a psychologických studijních textů
by: Daniela Králová, et al.
Published: (2017)

EGFR Inhibitors for Neoadjuvant and Adjuvant Therapy of NSCLC
by: Fabio Villa
Published: (2015)

Impact of NSCLC metabolic remodeling on immunotherapy effectiveness
by: Lulu Lv, et al.
Published: (2022)

Therapeutic Sequencing in ALK<sup>+</sup> NSCLC
by: Mei Elsayed, et al.
Published: (2021)

The role of immunotherapy in early-stage and metastatic NSCLC
by: Attila Lieber, et al.
Published: (2024)

The role of chemoradiotherapy and immunotherapy in stage III NSCLC
by: Zsuzsanna Orosz, et al.
Published: (2024)

Antitumor effect and molecular mechanism of fucoidan in NSCLC
by: Xiaohan Chen, et al.
Published: (2021)

Tracking circulating tumour‐associated T cells for the early diagnosis of cancer
by: Samuele Notarbartolo
Published: (2022)

The incidence of subclinical forms of urogenital tuberculosis in patients with pulmonary tuberculosis
by: Roman Zachoval, et al.
Published: (2018)

Vplyv pedagogickej zložky na formovanie osobnosti budúceho učiteľa
by: Pavol Masarik
Published: (2018)

Radiotherapy for NSCLC: Review of conventional and new treatment techniques
by: Ahmed Saadeddin
Published: (2012)

TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022)

Targeted therapeutic options in early and metastatic NSCLC-overview
by: Gabriella Gálffy, et al.
Published: (2024)

Fluid mechanics in circulating tumour cells: Role in metastasis and treatment strategies
by: Shivam Rajput, et al.
Published: (2023)

Isolation, Detection and Analysis of Circulating Tumour Cells: A Nanotechnological Bioscope
by: Upama Das, et al.
Published: (2023)

Etická dimenze profese pedagoga volného času
by: Michal Kaplánek
Published: (2019)

Tumour markers in pediatric solid tumours
by: Singal A, et al.
Published: (2005)

Oncogenic alterations in advanced NSCLC: a molecular super-highway
by: Alex Friedlaender, et al.
Published: (2024)

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
by: Xiaoying Hou, et al.
Published: (2018)

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
by: Wang Z, et al.
Published: (2014)

The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
by: Ji Li, et al.
Published: (2022)

Liquid biopsy in NSCLC: a new challenge in radiation therapy
by: Annarita Perillo, et al.
Published: (2021)

Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients
by: Luigi Della Gravara, et al.
Published: (2021)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
by: Chiara Agnoletto, et al.
Published: (2018)

Shoulder bandage with distal traction - application to athletes overusing
by: Zdeněk Florian, et al.
Published: (2005)

The Role of ADCY1 in Regulating the Sensitivity of Platinum-Based Chemotherapy in NSCLC
by: Ting Zou, et al.
Published: (2024)

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
by: Margherita Iaboni, et al.
Published: (2016)

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy
by: Santarpia M, et al.
Published: (2017)

The NEDD4/FLRT2 axis regulates NSCLC cell stemness
by: Yuping Yang, et al.
Published: (2024)

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC
by: Shao J, et al.
Published: (2024)

EGFR mutation testing in non-small cell lung cancer (NSCLC)
by: Fouad Al Dayel
Published: (2012)